Abstract
Since the initial observation that bacterial DNA is recognized by and activates cells of the immune system (reviewed in 1), substantial progress has been made with respect to the understanding of the molecular mechanisms involved. This bears upon both sides, the immunostimulatory DNA as a ligand and the immune cell with its receptor and signaling systems. In the meantime, it has been well established that the stimulatory capacity of bacterial DNA depends on short sequences with a central, unmethylated CG, called the CpG-motif (2,3). This stimulatory information can be transferred to single-stranded oligonucleotides (ODN). So far as it is known, all stimulatory activities of bacterial DNA are reflected in such ODNs. Therefore, these single-stranded ODNs might be regarded as the active principle of immunostimulatory DNA. It is however important to note that—as worked out with sophisticated arrays of ODNs—there is a clear species specificity in respect to the sequences active in mouse vs humans. Hence, it might be speculated that double-stranded bacterial DNA represents a pool of various stimulatory sequences that are recognized by specific but species-dependent receptor systems. DNA that harbors immunostimulatory capacity owing to CpG-motifs is collectively referred to as CpG-DNA.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Tokunaga, T., Yamamoto, T., and Yamamoto, S. (1999) How BCG led to the discovery of immunostimulatory DNA. Jpn. J. Infect. Dis. 52, 1–11.
Yamamoto, S., Yamamoto, T., Kataoka, T., Kuramoto, E., Yano, O. and Tokunaga, T. (1992) Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN- mediated natural killer activity. J. Immunol. 148, 4072–4076.
Krieg, A. M., Yi, A. K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., and Klinman, D. M. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546–549.
Wagner, H. (1999) Bacterial CpG DNA activates immune cells to signal infectious danger. Adv. Immunol. 73, 329–368.
Takeuchi, O., Hoshino, K., Kawai, T., et al. (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11, 443–451.
Means, T. K., Golenbock, D. T., and Fenton, M. J. (2000) The biology of Tolllike receptors. Cytokine. Growth Factor. Rev. 11, 219–232.
Wesche, H., Henzel, W.J., Shillinglaw, W., Li, S. & Cao, Z. (1997) MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7, 837–847.
Ishida, T., Mizushima, S., Azuma, S., et al. (1996) Identification of TRAF6, a novel tumor necrosis factor receptor- associated factor protein that mediates signaling from an amino- terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271, 28745–28748.
Baud, V., Liu, Z. G., Bennett, B., Suzuki, N., Xia, Y., and Karin, M. (1999) Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 13, 1297–1308.
Ghosh, S., May, M. J., and Kopp, E. B. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225–260.
Karin, M. and Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity (2000). Annu. Rev. Immunol. 18, 621–663.
Rothwarf, D. M., Zandi, E., Natoli, G. and Karin, M. (1998) IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395, 297–300.
Yamaoka, S., Courtois, G., Bessia, C., et al. (1998) Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93, 1231–1240.
Li, Q., Van Antwerp, D., Mercurio, F., Lee, K. F., and Verma, I. M. (1999) Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science, 284, 321–325.
Li, Z. W., Chu, W., Hu, Y., et al. (1999) The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189, 1839–1845.
Hu, Y., Baud, V., Delhase, M., et al. (1999) Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284, 316–320.
Karin, M. and Delhase, M. (1998) JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action? Proc. Natl. Acad. Sci. USA 95, 9067–9069.
Yin, L., Wu, L., Wesche, H., et al. (2001) Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 291, 2162–2165.
Deng, L., Wang, C., Spencer, E., et al. (2000) Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351–361.
Inohara, N., Koseki, T., Lin, J., et al. (2000) An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275, 27823–27831.
Poyet, J. L., Srinivasula, S. M., Lin, J. H., et al. (2000) Activation of the Ikappa B kinases by RIP via IKKgamma /NEMO-mediated oligomerization. J. Biol. Chem. 275, 37966–37977.
Stacey, K. J., Sweet, M. J. and Hume, D.A. (1996) Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157, 2116–2122.
Yi, A. K., Tuetken, R., Redford, T., Waldschmidt, M., Kirsch, J., and Krieg, A. M. (1998) CpG motifs in bacterial DNA activate leukocytes through the pH- dependent generation of reactive oxygen species. J. Immunol. 160, 4755–4761.
Sparwasser, T., Miethke, T., Lipford, G., et al. (1997) Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur. J. Immunol. 27, 1671–1679.
Yi, A. K., Klinman, D. M., Martin, T. L., Matson, S., and Krieg, A. M. (1996) Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J. Immunol. 157, 5394–5402.
Baeuerle, P. A. and Henkel, T. (1994) Function and activation of NF-kappa B in the immune system. Anna. Rev. Immunol. 12:141–79, 141–179.
Muroi, M., Muroi, Y., and Suzuki, T. (1994) The binding of immobilized IgG2a to Fc gamma 2a receptor activates NF- kappa B via reactive oxygen intermediates and tumor necrosis factor- alpha 1. J. Biol. Chem. 269, 30561–30568.
Muller, J. M., Rupec, R. A. and Baeuerle, P. A. (1997) Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods 11, 301–312.
Hacker, H., Vabulas, R. M., Takeuchi, O., et al. (2000) Immune Cell Activation by Bacterial CpG-DNA through Myeloid Differentiation Marker 88 and Tumor Necrosis Factor Receptor-Associated Factor (TRAF)6. J. Exp. Med. 192, 595–600.
Chu, W., Gong, X., Li, Z., et al. (2000) DNA-PKcs Is Required for Activation of Innate Immunity by Immunostimulatory DNA. Cell 103, 909–918.
Murphy, T. L., Cleveland, M. G., Kulesza, P., Magram, J., and Murphy, K. M. (1995) Regulation of interleukin 12 p40 expression through an NF-kappa B half- site. Mol. Cell Biol. 15, 5258–5267.
Plevy, S. E., Gemberling, J. H., Hsu, S., Dorner, A. J. and Smale, S. T. (1997) Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell Biol. 17, 4572–4588.
Sanjabi, S., Hoffmann, A., Liou, H. C., Baltimore, D., and Smale, S. T. (2000) Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. USA 97, 12705–12710.
Chang, L. and Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37–40.
Whitmarsh, A. J., Cavanagh, J., Tournier, C., Yasuda, J., and Davis, R. J. (1998) A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281, 1671–1674.
Schaeffer, H. J., Catling, A. D., Eblen, S. T., Collier, L.S., Krauss, A., and Weber, M. J. (1998) MP 1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281, 1668–1671.
Roussel, M. F. (1998) Key effectors of signal transduction and G1 progression. Adv. Cancer Res. 74, 1–24.
Sluss, H. K., Barrett, T., Derijard, B. and Davis, R. J. (1994) Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol. Cell Biol. 14, 8376–8384.
Westwick, J. K., Weitzel, C., Minden, A., Karin, M., and Brenner, D. A. (1994) Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J. Biol. Chem. 269, 26396–26401.
Bird, T. A., Kyriakis, J. M., Tyshler, L., Gayle, M., Milne, A. and Virca, G. D. (1994) Interleukin-1 activates p54 mitogen-activated protein (MAP) kinase/stress-activated protein kinase by a pathway that is independent of p21ras, Raf-1, and MAP kinase kinase. J. Biol. Chem. 269, 31836–31844.
Saklatvala, J., Davis, W. and Guesdon, F. (1996) Interleukin 1 (IL 1) and tumour necrosis factor (TNF) signal transduction. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 351, 151–157.
Hambleton, J., Weinstein, S. L., Lem, L., and DeFranco, A. L. (1996) Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide- stimulated macrophages. Proc. Natl. Acad. Sci. USA 93, 2774–2778.
Hacker, H., Mischak, H., Miethke, T., et al. (1998) CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17, 6230–6240.
Karin, M., Liu Zg, and Zandi, E. (1997) AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240–246.
Smeal, T., Binetruy, B., Mercola, D., et al. (1992) Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol. Cell Biol. 12, 3507–3513.
Sanchez, I., Hughes, R. T., Mayer, B. J., Yee, K., Woodgett, J. R., Avruch, J., Kyriakis, J. M., and Zon, L. I. (1994) Role of SAPK/ERK kinase-1 in the stressactivated pathway regulating transcription factor c-Jun. Nature 372, 794–798.
Gupta, S., Campbell, D., Derijard, B. and Davis, R. J. (1995) Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267, 389–393.
Raingeaud, J., Whitmarsh, A. J., Barrett, T., Derijard, B., and Davis, R. J. (1996) MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen- activated protein kinase signal transduction pathway. Mol. Cell Biol. 16, 1247–1255.
Yi, A. K., Chang, M., Peckham, D. W., Krieg, A. M., and Ashman, R. F. (1998) CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J. Immunol. 160, 5898–5906.
Sanghera, J. S., Weinstein, S. L., Aluwalia, M., Girn, J., and Pelech, S. L. (1996) Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages. J. Immunol. 156, 4457–4465.
Hacker, H., Mischak, H., Hacker, G., et al. (1999) Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells. EMBO J. 18, 6973–6982.
Sester, D. P., Beasley, S. J., Sweet, M. J., et al. (1999) Bacterial/CpG DNA down-modulates colony stimulating factor-1 receptor surface expression on murine bone marrow-derived macrophages with concomitant growth arrest and factor-independent survival. J. Immunol. 163, 6541–6550.
Buscher, D., Hipskind, R. A., Krautwald, S., Reimann, T. and Baccarini, M. (1995) Ras-dependent and -independent pathways target the mitogen-activated protein kinase network in macrophages. Mol. Cell Biol. 15, 466–475.
Geppert, T. D., Whitehurst, C. E., Thompson, P., and Beutler, B. (1994) Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Mol. Med. 1, 93–103.
Yi, A. K. and Krieg, A. M. (1998) Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J. Immunol. 161, 4493–4497.
Lu, H. T., Yang, D. D., Wysk, M., Gatti, E., Mellman, I., Davis, R. J., and Flavell, R. A. (1999) Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18, 1845–1857.
Winzen, R., Kracht, M., Ritter, B., et al. (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18, 4969–4980.
Prichett, W., Hand, A., Sheilds, J., and Dunnington, D. (1995) Mechanism of action of bicyclic imidazoles defines a translational regulatory pathway for tumor necrosis factor alpha. J. Inflamm. 45, 97–105.
Feng, G. J., Goodridge, H. S., Harnett, M. M., et al. (1999) Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J. Immunol. 163, 6403–6412.
Medzhitov, R. and Janeway, C. (2000) The Toll receptor family and microbial recognition. Trends. Microbiol. 8, 452–456.
Sparwasser, T., Koch, E. S., Vabulas, R. M., et al. (1998) Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28, 2045–2054.
Schnare, M., Holt, A. C., Takeda, K., Akira, S., and Medzhitov, R. (2000) Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88. Curr. Biol. 10, 1139–1142.
Du, X., Poltorak, A., Wei, Y., and Beutler, B. (2000) Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine. Netw. 11, 362–371.
Chuang, T. H. and Ulevitch, R. J. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. (2000) Eur. Cytokine. Netw., 11, 372–378.
Hemmi, H., Takeuchi, O., Kawai, T., et al. (2000) Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745.
Smith, G. C. and Jackson, S. P. (1999) The DNA-dependent protein kinase. Genes Dev. 13, 916–934.
Hammarsten, O., DeFazio, L. G. and Chu, G. (2000) Activation of DNAdependent protein kinase by single-stranded DNA ends. J. Biol. Chem. 275, 1541–1550.
Poltorak, A., He, X., Smirnova, I., et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088.
Hoshino, K., Takeuchi, O., Kawai, T., et al. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749–3752.
Inohara, N., Ogura, Y., Chen, F. F., Muto, A., and Nunez, G. (2001) Human Nod1 Confers Responsiveness to Bacterial Lipopolysaccharides. J. Biol. Chem. 276, 2551–2554
Inohara, N., Koseki, T., del Peso, L., et al. (1999) Nod 1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem. 274, 14560–14567.
Ogura, Y., Inohara, N., Benito, A., Chen, F. F., Yamaoka, S., and Nunez, G. (2001) Nod2, a Nod 1 /Apaf-1 family member that is restricted to monocytes and activates NF{kappa}B. J. Biol. Chem. 276, 2551–2554.
Macfarlane, D. E. and Manzel, L. (1998) Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J. Immunol. 160, 1122–1131.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Häcker, H. (2002). Signal Transduction Pathways Activated By CpG-DNA. In: Raz, E. (eds) Microbial DNA and Host Immunity. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-305-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-59259-305-7_3
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9728-1
Online ISBN: 978-1-59259-305-7
eBook Packages: Springer Book Archive